Menu
Annual · values202520242023
Operating Cash Flow-28.61 M USD-14.14 M USD-14.15 M USD
Depreciation & Amortization2.91 M USD1.90 M USD1.64 M USD
Stock-Based Compensation996000 USD754000 USD
Capital Expenditures7.41 M USD4.01 M USD-2.75 M USD
Cash Flow from Investing-95.60 M USD13.96 M USD
Cash Flow from Financing144.96 M USD66000 USD
Dividends Paid
Stock Buybacks
Free Cash Flow-36.02 M USD-18.16 M USD-15.89 M USD

Shoulder Innovations, Inc. is a medical technology company that designs, develops, manufactures, and distributes implant replacement systems for shoulder arthroplasty in the United States. The company focuses on transforming the shoulder surgical care market by providing advanced shoulder implant solutions and related technologies that support preoperative planning, implant selection, and procedural efficiency. Shoulder Innovations’ portfolio centers on its InSet Glenoid and other implant systems, engineered to enhance fixation, reduce mechanical stress at the bone-implant interface, and improve stability in shoulder joint reconstruction. These products are used by orthopedic surgeons to treat patients requiring shoulder replacement due to degenerative conditions, trauma, or other pathologies. Operating as a commercial-stage enterprise, Shoulder Innovations serves hospitals and surgical centers through specialized sales channels and clinical relationships. Founded in 2009 and headquartered in Grand Rapids, Michigan, the company plays a specialized role within the orthopedic and broader medical device market by concentrating exclusively on shoulder-focused solutions.